Sentences with phrase «research on cardiovascular diseases»

Erik Ingelsson, at SciLifeLab and Uppsala University, has received the award in medicine for his research on cardiovascular diseases.

Not exact matches

His research focuses on two major themes: (a) clinical research in cardiovascular disease and diabetes and (b) research related to food policy and the dietary determinants of ill health.

Intrigued by the medical applications of basic research, she rotated through laboratories in cardiology and cardiovascular disease before settling on Church's group.

In a 2006 review of 842 scientific papers on omega - 3 fatty acids and cardiovascular disease, a research team based at the TuftsNew England Medical Center in Boston concluded that only EPA and DHA seemed beneficial — ALA, their plant - produced precursor, was not.

Another recently published systematic review and meta - analysis by Dr. Sievenpiper's research group found that eating on average one serving a day of beans, peas, chickpeas or lentils can also reduce «bad cholesterol» by five per cent and therefore lower the risk of cardiovascular disease.

The research, which provides an update for 2014 on the burden of cardiovascular disease (CVD) in Europe, shows that death rates from CVD (diseases of the heart and blood vessels) vary enormously.

In the most comprehensive study ever on the impact of smoking on cardiovascular disease in older people, epidemiologist Dr. Ute Mons from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) analyzed 25 individual studies, compiling data from over half a million individuals age 60 and older.

Past research has largely looked at people with existing cardiovascular disease (prevalent disease), rather than focusing on those newly diagnosed (incident disease).

«Poverty and the many stresses that come with social disadvantage have long been linked to cardiovascular disease, but how we live, work, and play has a great impact on heart health for people from a broad range of economic and cultural backgrounds,» explains David Siscovick, MD, MPH, Senior Vice President for Research at The New York Academy of Medicine and Chair of the American Heart Association's (AHA) Council on Epidemiology and Prevention.

Previous research has shown that being sedentary increases the risk of cardiovascular disease but until now its effect on patients with established heart disease was unknown.

Raydiance's technology has attracted the attention of the U.S. Food and Drug Administration (FDA), which in July 2007 signed the company to a two - year cooperative research and development agreement that has allowed the FDA's Center for Devices and Radiological Health (CDRH) to evaluate the use, safety and effectiveness of Raydiance's USP laser system in a number of areas, including the ablation of corneal tissues in refractive surgery and corneal repair; the administration of light therapy for treating cancer, cardiovascular disease and diabetes; and the removal of plaque on teeth without damaging the enamel.

Forthcoming research planned by the group will focus on isolated vitamin D supplementation and indicators of cardiovascular disease in postmenopausal women.

On the research applications front, Dr. Chia Tet Fatt, a young scientist from the Natural Sciences Academic Group at the National Institute of Education, revealed Singapore's very first genetically modified organism (GMO)-- a transgenic resveratrol producing red lettuce for the prevention of cancer and cardiovascular diseases — which was developed by introducing the stilbene synthase gene into a red plant and diverting the precursors into resveratrol synthesis.

Depression, even when undiagnosed, can have many negative effects on cardiovascular patients, including poor healthcare experiences, more use of healthcare resources and higher health costs, according to preliminary research presented at the American Heart Association's Quality of Care and Outcomes Research Scientific Sessions 2018, a premier global exchange of the latest advances in quality of care and outcomes research in cardiovascular disease and stroke for researchers, healthcare professionals and policresearch presented at the American Heart Association's Quality of Care and Outcomes Research Scientific Sessions 2018, a premier global exchange of the latest advances in quality of care and outcomes research in cardiovascular disease and stroke for researchers, healthcare professionals and policResearch Scientific Sessions 2018, a premier global exchange of the latest advances in quality of care and outcomes research in cardiovascular disease and stroke for researchers, healthcare professionals and policresearch in cardiovascular disease and stroke for researchers, healthcare professionals and policymakers.

JACC is the flagship for a family of journals — JACC: Cardiovascular Interventions, JACC: Cardiovascular Imaging, JACC: Heart Failure, JACC: Clinical Electrophysiology and JACC: Basic to Translational Science — that prides themselves in publishing the top peer - reviewed research on all aspects of cardiovascular disease.

Their research focused on type 1 diabetes, for which cardiovascular disease accounts for 65 — 75 % of deaths.

She directed The Johns Hopkins Center of Excellence for Aging Research, the Center on Aging and Health, and the Division of Geriatric Medicine and Gerontology, and led major multidisciplinary research programs on the causes and consequences of frailty, cardiovascular disease, cognitive impairment and disability in older adults, and approaches to preResearch, the Center on Aging and Health, and the Division of Geriatric Medicine and Gerontology, and led major multidisciplinary research programs on the causes and consequences of frailty, cardiovascular disease, cognitive impairment and disability in older adults, and approaches to preresearch programs on the causes and consequences of frailty, cardiovascular disease, cognitive impairment and disability in older adults, and approaches to prevention.

Dr. Saptarsi Haldar's research focuses on how cells in the cardiovascular system control gene expression and how these gene control mechanisms go awry during disease.

Dr. Conklin's research focuses on human genetics that lead to cardiovascular diseases, such as cardiac arrhythmias and cardiomyopathy.

Our research is focused on understanding how the functions of immune cells, such as monocytes and T lymphocytes, change during the progression of cardiovascular disease and cancer.

Gladstone, which is affiliated with UCSF, is a leading and independent biomedical - research organization that focuses on cardiovascular disease, neurodegenerative disease and viral infections.

SAN FRANCISCO, CA — A new biopharmaceutical company, Tenaya Therapeutics Inc., will build on discoveries in cardiovascular disease research made at the Gladstone Institutes, concentrating on regenerative medicine and drug discovery for heart failure.

One research program focuses on the role of myeloperoxidase, a leukocyte heme protein, in promoting oxidant stress in vivo, and its participation in cardiovascular diseases.

Susan Amara, USA - «Regulation of transporter function and trafficking by amphetamines, Structure - function relationships in excitatory amino acid transporters (EAATs), Modulation of dopamine transporters (DAT) by GPCRs, Genetics and functional analyses of human trace amine receptors» Tom I. Bonner, USA (Past Core Member)- Genomics, G protein coupled receptors Michel Bouvier, Canada - Molecular Pharmacology of G protein - Coupled Receptors; Molecular mechanisms controlling the selectivity and efficacy of GPCR signalling Thomas Burris, USA - Nuclear Receptor Pharmacology and Drug Discovery William A. Catterall, USA (Past Core Member)- The Molecular Basis of Electrical Excitability Steven Charlton, UK - Molecular Pharmacology and Drug Discovery Moses Chao, USA - Mechanisms of Neurotophin Receptor Signaling Mark Coles, UK - Cellular differentiation, human embryonic stem cells, stromal cells, haematopoietic stem cells, organogenesis, lymphoid microenvironments, develomental immunology Steven L. Colletti, USA Graham L Collingridge, UK Philippe Delerive, France - Metabolic Research (diabetes, obesity, non-alcoholic fatty liver, cardio - vascular diseases, nuclear hormone receptor, GPCRs, kinases) Sir Colin T. Dollery, UK (Founder and Past Core Member) Richard M. Eglen, UK Stephen M. Foord, UK David Gloriam, Denmark - GPCRs, databases, computational drug design, orphan recetpors Gillian Gray, UK Debbie Hay, New Zealand - G protein - coupled receptors, peptide receptors, CGRP, Amylin, Adrenomedullin, Migraine, Diabetes / obesity Allyn C. Howlett, USA Franz Hofmann, Germany - Voltage dependent calcium channels and the positive inotropic effect of beta adrenergic stimulation; cardiovascular function of cGMP protein kinase Yu Huang, Hong Kong - Endothelial and Metabolic Dysfunction, and Novel Biomarkers in Diabetes, Hypertension, Dyslipidemia and Estrogen Deficiency, Endothelium - derived Contracting Factors in the Regulation of Vascular Tone, Adipose Tissue Regulation of Vascular Function in Obesity, Diabetes and Hypertension, Pharmacological Characterization of New Anti-diabetic and Anti-hypertensive Drugs, Hypotensive and antioxidant Actions of Biologically Active Components of Traditional Chinese Herbs and Natural Plants including Polypehnols and Ginsenosides Adriaan P. IJzerman, The Netherlands - G protein - coupled receptors; allosteric modulation; binding kinetics Michael F Jarvis, USA - Purines and Purinergic Receptors and Voltage-gated ion channel (sodium and calcium) pharmacology Pain mechanisms Research Reproducibility Bong - Kiun Kaang, Korea - G protein - coupled receptors; Glutamate receptors; Neuropsychiatric disorders Eamonn Kelly, Prof, UK - Molecular Pharmacology of G protein - coupled receptors, in particular opioid receptors, regulation of GPCRs by kinasis and arrestins Terry Kenakin, USA - Drug receptor pharmacodynamics, receptor theory Janos Kiss, Hungary - Neurodegenerative disorders, Alzheimer's disease Stefan Knapp, Germany - Rational design of highly selective inhibitors (so call chemical probes) targeting protein kinases as well as protein interaction inhibitors of the bromodomain family Andrew Knight, UK Chris Langmead, Australia - Drug discovery, GPCRs, neuroscience and analytical pharmacology Vincent Laudet, France (Past Core Member)- Evolution of the Nuclear Receptor / Ligand couple Margaret R. MacLean, UK - Serotonin, endothelin, estrogen, microRNAs and pulmonary hyperten Neil Marrion, UK - Calcium - activated potassium channels, neuronal excitability Fiona Marshall, UK - GPCR molecular pharmacology, structure and drug discovery Alistair Mathie, UK - Ion channel structure, function and regulation, pain and the nervous system Ian McGrath, UK - Adrenoceptors; autonomic transmission; vascular pharmacology Graeme Milligan, UK - Structure, function and regulation of G protein - coupled receptors Richard Neubig, USA (Past Core Member)- G protein signaling; academic drug discovery Stefan Offermanns, Germany - G protein - coupled receptors, vascular / metabolic signaling Richard Olsen, USA - Structure and function of GABA - A receptors; mode of action of GABAergic drugs including general anesthetics and ethanol Jean - Philippe Pin, France (Past Core Member)- GPCR - mGLuR - GABAB - structure function relationship - pharmacology - biophysics Helgi Schiöth, Sweden David Searls, USA - Bioinformatics Graeme Semple, USA - GPCR Medicinal Chemistry Patrick M. Sexton, Australia - G protein - coupled receptors Roland Staal, USA - Microglia and neuroinflammation in neuropathic pain and neurological disorders Bart Staels, France - Nuclear receptor signaling in metabolic and cardiovascular diseases Katerina Tiligada, Greece - Immunopharmacology, histamine, histamine receptors, hypersensitivity, drug allergy, inflammation Georg Terstappen, Germany - Drug discovery for neurodegenerative diseases with a focus on AD Mary Vore, USA - Activity and regulation of expression and function of the ATP - binding cassette (ABC) transporters

Metabolic research focuses on better understanding basic biological mechanisms that regulate metabolism and how they are dysregulated in disorders such as obesity, diabetes, cardiovascular disease, and cancer.

Vasculata ™ 2018 will be an intense 3 1/2 day course introducing the basics of cardiovascular biology and cardiovascular disease with an emphasis on new approaches to treating the most common causes of human disease in our society, based on cutting - edge research in the field.

The Area of Genomic Medicine is devised as a scientific production structure which will preferably include research groups centred on work in the area of genetic epidemiology of some of the main public health problems (cancer, autoimmune diseases, cardiovascular diseases, diabetes, rare diseases, etc.).

A recent review published in the European Journal of Nutrition of the existing research on dairy fat came to some surprising conclusions: People who eat full - fat dairy are no more likely to develop cardiovascular disease and type 2 diabetes than people who stick to low - fat dairy.

According to a research from James J. Di Nicolantonio, a cardiovascular research scientist at St. Luke's Mid-Atlantic Heart Institute in Kansas City, by cutting back on added sugar you cut down risk of heart diseases by three times.

However, researchers in the Department of Animal Science at Texas A&M University have published the only two research studies that actually compared the effects of ground beef from grass - fed cattle and traditional, grain - fed cattle on risk factors for cardiovascular disease (CVD) and type II diabetes in men.

He taught me a lot about evolutionary medicine and nutrition in general, opened many doors and introduced me (directly and indirectly) to various players in this field, such as Dr. Boyd Eaton (one of the fathers of evolutionary nutrition), Maelán Fontes from Spain (a current research colleague and close friend), Alejandro Lucia (a Professor and a top researcher in exercise physiology from Spain, with whom I am collaborating), Ben Balzer from Australia (a physician and one of the best minds in evolutionary medicine), Robb Wolf from the US (a biochemist and the best «biohackers I know»), Óscar Picazo and Fernando Mata from Spain (close friends who are working with me at NutriScience), David Furman from Argentina (a top immunologist and expert in chronic inflammation working at Stanford University, with whom I am collaborating), Stephan Guyenet from the US (one of my main references in the obesity field), Lynda Frassetto and Anthony Sebastian (both nephrologists at the University of California San Francisco and experts in acid - base balance), Michael Crawford from the UK (a world renowned expert in DHA and Director of the Institute of Brain Chemistry and Human Nutrition, at the Imperial College London), Marcelo Rogero (a great researcher and Professor of Nutrigenomics at the University of Sao Paulo, Brazil), Sérgio Veloso (a cell biologist from Portugal currently working with me, who has one of the best health blogs I know), Filomena Trindade (a Portuguese physician based in the US who is an expert in functional medicine), Remko Kuipers and Martine Luxwolda (both physicians from the Netherlands, who conducted field research on traditional populations in Tanzania), Gabriel de Carvalho (a pharmacist and renowned nutritionist from Brazil), Alex Vasquez (a physician from the US, who is an expert in functional medicine and Rheumatology), Bodo Melnik (a Professor of Dermatology and expert in Molecular Biology from Germany, with whom I have published papers on milk and mTOR signaling), Johan Frostegård from Sweden (a rheumatologist and Professor at Karolinska Institutet, who has been a pioneer on establishing the role of the immune system in cardiovascular disease), Frits Muskiet (a biochemist and Professor of Pathophysiology from the Netherlands, who, thanks to his incredible encyclopedic knowledge and open - mind, continuously teaches me more than I could imagine and who I consider a mentor), and the Swedish researchers Staffan Lindeberg, Tommy Jönsson and Yvonne Granfeldt, who became close friends and mentors.

Newer research confirms many of the old findings on these chemicals — endocrine disruption (in adults and babies), thyroid disruption, and increase risk of cardiovascular disease, diabetes and liver enzyme abnormalities.3 And recently, the Yale School of Medicine found that BPA «causes the loss of connections of brain cells,» which increases the risk for memory problems and even depression.4

The research was inspired by studies that looked at the effect of diet and lifestyle changes on other diseases, such as cardiovascular disease, cancer, and HIV.

According to U of Virginia's Research News, based on her review of yoga studies, Innes considers yoga a promising therapy for preventing and managing cardiovascular disease and related chronic conditions.

The science is clear that high quality saturated and mono unsaturated fats are better for you than poly unsaturated and trans fats, and it also seems clear that eating small amounts of these high - quality fats may be beneficial... But there is absolutely zero evidence to suggest that basing one's diet on these fats is beneficial in the long run, and there is several decades» worth of research to suggest that eating too much fat and animal products is linked to cardiovascular disease.

Although research on meditation and cardiovascular health is fairly limited, some studies suggest that taking up a meditation practice may boost your defense against heart disease (the leading cause of death in the United States).

Some research has found a link between dental health and cardiovascular disease, meaning chia seeds may have some direct, and indirect positive effects on your heart health.

Health research on millet shows it could be helpful in preventing cardiovascular disease and controlling blood glucose levels in diabetics (10,11).

Recent research shows that artificially lowering blood pressure with drugs has virtually no effect on cardiovascular disease risk, compared to lowering readings with natural fruit polyphenols, diet and physical activity.

Seven strong areas of research on how pets positively impact human health have now been identified, including: childhood allergies and immunity, Alzheimer's / dementia, depression, autism, cardiovascular disease, post-traumatic stress disorder (PTSD) and neurological disorders.

The faculty research tends to focus on such public health issues as TB, obesity, and cardiovascular disease, though that focus is expanding into new research areas such as genetics and how the field impacts communicable disease.

Participants were just over 49 years old on average at the beginning of the research and had no indicators of cardiovascular disease.

Results - oriented, hands - on large clinical trial experience in cardiovascular devices and medications; one and half year Chief Medical Officer in an International hospital in China, more than ten years invasive / interventional cardiologist and five years Director of Coronary Care Unit (CCU) in one of the first - class hospitals in China; more than ten years preclinical research experience in the field of cardiovascular disease...

While there is a growing appreciation of the impact of child maltreatment on cardiovascular disease risk over the life course, 40 there has been a paucity of research to date that has explored the impact of family violence on obesity risk in early life.